Close Menu

consumer genomics

Ancestry will focus more on family history and genetic genealogy, and called the move a "strategic but difficult decision."

The PCR test is the first offering from the firm, formerly known as Concepta, since it acquired Manchester-based startup The Genome Store in November.

Developed by Lausanne University Hospital and presented at AMIA, the technology simulates malicious attacks on personal genomic data to risk scores for specific disclosures.

With the new funding, the informatics and small-panel genetic testing firm looks to expand its IT capabilities and offer new DTC screening tests.

Data privacy firm Oasis Labs will offer a consumer-controlled data management app to customers of the DNA testing company, which was cofounded by George Church.

Driving the shift is a belief that standard STR testing is not always a reliable tool for determining complex family relationships.

The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing.

The New York-based multinational investment company will acquire Ancestry from current stakeholders Silver Lake, Spectrum Equity, Permira, and others.

The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.

Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.

Pages

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.